A detailed history of Gamma Investing LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Gamma Investing LLC holds 27,386 shares of BMY stock, worth $1.54 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
27,386
Previous 16,976 61.32%
Holding current value
$1.54 Million
Previous $705 Million 100.98%
% of portfolio
0.14%
Previous 0.1%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$39.66 - $51.75 $412,860 - $538,717
10,410 Added 61.32%
27,386 $1.42 Billion
Q2 2024

Jul 02, 2024

SELL
$40.25 - $52.99 $18,032 - $23,739
-448 Reduced 2.57%
16,976 $705 Million
Q1 2024

Apr 05, 2024

BUY
$47.98 - $54.4 $208,617 - $236,531
4,348 Added 33.25%
17,424 $945 Million
Q4 2023

Feb 01, 2024

BUY
$48.48 - $57.85 $633,924 - $756,446
13,076 New
13,076 $639 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.